Literature DB >> 14617103

Molecular mechanisms of cis-urocanic acid and permethrin-induced alterations in cutaneous immunity.

M R Prater1, B L Blaylock, S D Holladay.   

Abstract

BACKGROUND/
PURPOSE: Cutaneous cis-urocanic acid (cUCA) or ultraviolet B exposure has been shown to cause diminished cutaneous contact hypersensitivity (CH) and to induce systemic tolerance (increased regulatory T lymphocytes) in mice. Permethrin is also a known CH inhibitor, but the molecular mechanisms are currently poorly understood. In this study, CH was evaluated in four strains of mice: an immunosensitive strain (C57BL/6N), an immunoresistant strain (SvImJ), a strain developed from C57BL/6N mice but genetically altered at both the tumor necrosis factor-alpha receptors (TNFalphap55R and p75R), and a strain developed from C57BL/6N but genetically deleted at the interferon-gamma (IFNgamma) locus.
METHODS: CH was evaluated in each group via oxazolone challenge following a 5-day exposure to intradermal (ID) cUCA or a single exposure to topical permethrin, or co-exposure to both chemicals in 5-week-old female C57BL/6N, SvImJ, and C57BL/6N mice genetically altered at the TNFalpha or IFNgamma locus.
RESULTS: A 5-day exposure to ID cUCA or a single exposure to topical permethrin resulted in diminished CH response in C57BL/6N mice, and this effect was exacerbated with concurrent exposure to both chemicals. CH in SvImJ was both cUCA- and permethrin-resistant relative to C57BL/6N mice, as 5-day cUCA or a single exposure to permethrin did not diminish CH, nor did concurrent exposure to cUCA and permethrin. Mice deleted at both TNFalphaR loci displayed similar but somewhat blunted diminished CH responses to cUCA or permethrin. This trend became significant with combined chemical exposure. IFNgamma knockout mice displayed similar diminished CH responses to cUCA or permethrin alone. Unlike C57BL/6N mice, the IFNgamma knockout mice did not show a further reduction in CH with combined chemical exposure.
CONCLUSIONS: These results suggest the following: (1)Mouse strains show variable susceptibility to permethrin- and cUCA-induced immunomodulation. (2)TNFalpha may be involved in the immunomodulatory effects of cUCA and permethrin. (3)IFNgamma may be required for the more than additive depression of CH caused by cUCA+permethrin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14617103     DOI: 10.1046/j.1600-0781.2003.00058.x

Source DB:  PubMed          Journal:  Photodermatol Photoimmunol Photomed        ISSN: 0905-4383            Impact factor:   3.135


  5 in total

1.  Cis-urocanic acid suppresses UV-B-induced interleukin-6 and -8 secretion and cytotoxicity in human corneal and conjunctival epithelial cells in vitro.

Authors:  J Viiri; H M Jauhonen; A Kauppinen; T Ryhänen; T Paimela; J Hyttinen; I Sorri; J K Laihia; L Leino; K Kaarniranta
Journal:  Mol Vis       Date:  2009-09-08       Impact factor: 2.367

2.  cis-Urocanic acid attenuates acute dextran sodium sulphate-induced intestinal inflammation.

Authors:  Eric Albert; John Walker; Aducio Thiesen; Thomas Churchill; Karen Madsen
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

3.  An action spectrum (290-320 nm) for TNFalpha protein in human skin in vivo suggests that basal-layer epidermal DNA is the chromophore.

Authors:  Susan L Walker; Antony R Young
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-19       Impact factor: 11.205

4.  Cis-urocanic acid inhibits SAPK/JNK signaling pathway in UV-B exposed human corneal epithelial cells in vitro.

Authors:  Hanna-Mari Jauhonen; Anu Kauppinen; Tuomas Paimela; Jarmo K Laihia; Lasse Leino; Antero Salminen; Kai Kaarniranta
Journal:  Mol Vis       Date:  2011-08-27       Impact factor: 2.367

Review 5.  Fernblock (Polypodium leucotomos Extract): Molecular Mechanisms and Pleiotropic Effects in Light-Related Skin Conditions, Photoaging and Skin Cancers, a Review.

Authors:  Concepcion Parrado; Marta Mascaraque; Yolanda Gilaberte; Angeles Juarranz; Salvador Gonzalez
Journal:  Int J Mol Sci       Date:  2016-06-29       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.